학술논문
LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1297-S1298
Subject
Language
ISSN
0923-7534